Vivos Therapeutics Inc (NASDAQ: VVOS) focused on developing innovative diagnostic treatments and announced that the company’s latest innovation (drug) for treating dental tissue anomalies and dentofacial malformation shows the efficacy for the treatment OSA. Satisfactory outcome: Independent study by The EyeDeas Company on the patients’ survey, indicated that 97 percent […]